+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Nanotechnology in Medical Devices Market Report and Forecast 2023-2031

  • PDF Icon

    Report

  • 147 Pages
  • May 2023
  • Region: Global
  • Expert Market Research
  • ID: 5805765
The global nanotechnology in medical devices market value was USD 5.35 billion in 2022, driven by the growing adoption of advanced healthcare technologies across the globe. The market size is anticipated to grow at a CAGR of 11.3% during the forecast period of 2023-2031 to achieve a value of USD 14 billion by 2031.

Introduction

Nanotechnology in the field of medicine has brought about groundbreaking advancements, revolutionizing the diagnosis, treatment, and prevention of diseases. Nanotechnology involves the manipulation and control of materials and devices at the nanoscale level, typically ranging from 1 to 100 nanometers. At this scale, materials exhibit unique properties and behaviors that can be harnessed for medical applications.

Nanotechnology has found wide-ranging applications in medicine, including drug delivery systems, diagnostics, imaging, tissue engineering, regenerative medicine, and biosensors. The ability to engineer nanoparticles and nanomaterials with specific properties has enabled targeted drug delivery, enhanced imaging capabilities, and improved treatment outcomes. Moreover, nanotechnology offers the potential for personalized medicine, where treatments can be tailored to individual patients based on their specific needs.

Key Trends in the Nanotechnology in Medical Devices Market

Some key trends involved in the nanotechnology in medical devices market are as follows:
  • Targeted Drug Delivery: Nanoparticles can be engineered to carry drugs and selectively target specific cells or tissues, increasing the effectiveness of treatment while minimizing side effects. This targeted drug delivery approach is a key trend in nanomedicine, allowing for more precise and efficient drug delivery
  • Diagnostic Nanotechnology: Nanoparticles can be used in diagnostic tests to detect biomarkers and provide rapid and sensitive results. Nanotechnology-based diagnostic tools offer improved accuracy, sensitivity, and portability, enabling early detection and diagnosis of diseases
  • Regenerative Medicine and Tissue Engineering: Nanomaterials can be used to create scaffolds and support structures for tissue regeneration and repair. Nanotechnology-based approaches hold promise in enhancing tissue regeneration, promoting wound healing, and developing functional replacements for damaged tissues and organs
  • Nano-based Imaging Technologies: Nanoparticles can be employed as contrast agents in various imaging modalities, such as magnetic resonance imaging (MRI), computed tomography (CT), and fluorescence imaging. These nanomaterials enable improved imaging resolution and provide real-time visualization of biological processes at the molecular level
  • Point-of-Care Nanodevices: The development of portable and user-friendly nanodevices for point-of-care diagnostics is a growing trend. These devices enable rapid and on-site testing, reducing the need for laboratory-based diagnostic procedures and allowing for faster diagnosis and treatment decisions

Nanotechnology in Medical Devices Market Segmentations

Market by Product

Active Implantable Devices

  • Cardiac Rhythm Management Devices
  • Hearing Aid Devices
  • Retinal Implants

Biochips

  • DNA Microarrays
  • Lab-On-Chip

Implantable Materials

  • Dental Restorative Materials
  • Bone Substitute Materials

Medical Textiles

  • Wound Dressings
  • Others

Market Breakup by Applications

  • Therapeutic Applications
  • Diagnostic Applications
  • Research Applications
  • Others

Market Breakup by End User

  • Hospitals and Clinics
  • Long Term Care Centers
  • Households
  • Home Care Settings
  • Ambulatory Surgical Centers
  • Urgent Care Center
  • Others

Market Breakup by Distribution Channel

  • Wholesalers/Distributors
  • Online Retailers
  • Multi-brand Stores
  • Specialty Stores
  • Others

Market Breakup by Region

North America

  • United States of America
  • Canada

Europe

  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Nanotechnology in Medical Devices Market Scenario

The market for nanotechnology in the medical field, often referred to as nanomedicine, is witnessing significant growth and is poised to revolutionize healthcare. Nanotechnology offers unique opportunities to address unmet medical needs, improve treatment outcomes, and enhance patient care. The market is driven by factors such as increasing demand for personalized medicine, advancements in nanomaterials and nanofabrication techniques, and growing investment in research and development activities.

The use of nanotechnology in medicine has resulted in the development of innovative products and solutions across various medical domains. Nanoparticles, nanoscale devices, and nanomaterials are being used in drug delivery systems, imaging agents, diagnostic tools, regenerative medicine, and other applications. These technologies enable targeted drug delivery, enhanced imaging capabilities, improved tissue regeneration, and more precise diagnostic procedures.

The global market for nanomedicine is experiencing substantial growth due to rising incidences of chronic diseases, increasing geriatric population, and the growing adoption of advanced healthcare technologies. Additionally, supportive government initiatives, favorable reimbursement policies, and collaborations between academic institutions and pharmaceutical companies are driving market growth.

In conclusion, the nanomedicine market offers immense potential for transforming healthcare delivery and improving patient outcomes. With ongoing technological advancements and increasing investments, the market is expected to witness substantial growth in the coming years. The integration of nanotechnology in medicine holds promise for addressing complex medical challenges and revolutionizing healthcare practices.

Nanotechnology in Medical Devices Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • 3M
  • Dentsply Sirona
  • Thermo Fisher Scientific
  • PerkinElmer Inc
  • General Electric Company
  • Ferro Corporation
  • Eppendorf AG
  • Merck KGaA
  • ZELLMECHANIK DRESDEN
  • TÜV Rheinland
  • Medtronic
  • Boston Scientific Corporation
  • BIOTRONIK
  • LivaNova PLC
  • Demant A/S

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Nanotechnology in Medical Devices Market Overview
3.1 Global Nanotechnology in Medical Devices Market Historical Value (2016-2022)
3.2 Global Nanotechnology in Medical Devices Market Forecast Value (2023-2031)
4 Global Nanotechnology in Medical Devices Market Landscape
4.1 Global Nanotechnology in Medical Devices Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Nanotechnology in Medical Devices Product Landscape
4.2.1 Analysis by Type of Devices
4.2.2 Analysis by End User
4.2.3 Analysis by Distribution Channel
5 Global Nanotechnology in Medical Devices Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Nanotechnology in Medical Devices Market Segmentation
6.1 Global Nanotechnology in Medical Devices Market by Product
6.1.1 Market Overview
6.1.2 Active Implantable Devices
6.1.2.1 Cardiac Rhythm Management Devices
6.1.2.2 Hearing Aid Devices
6.1.2.3 Retinal Implants
6.1.3 Biochips
6.1.3.1 DNA Microarrays
6.1.3.2 Lab-On-Chip
6.1.4 Implantable Materials
6.1.4.1 Dental Restorative Materials
6.1.4.2 Bone Substitute Materials
6.1.5 Medical Textiles
6.1.6 Wound Dressings
6.1.7 Others
6.2 Global Nanotechnology in Medical Devices Market by Applications
6.2.1 Market Overview
6.2.2 Therapeutic Applications
6.2.3 Diagnostic Applications
6.2.4 Research Applications
6.2.5 Others
6.3 Global Nanotechnology in Medical Devices Market by End User
6.3.1 Market Overview
6.3.2 Hospitals and Clinics
6.3.3 Long Term Care Centers
6.3.4 Households
6.3.5 Home Care Settings
6.3.6 Ambulatory Surgical Centers
6.3.7 Urgent Care Center
6.3.8 Others
6.4 Global Nanotechnology in Medical Devices Market by Distribution Channel
6.4.1 Market Overview
6.4.2 Wholesalers/Distributors
6.4.3 Online Retailers
6.4.4 Multi-brand Stores
6.4.5 Specialty Stores
6.4.6 Others
6.5 Global Nanotechnology in Medical Devices Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Nanotechnology in Medical Devices Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Nanotechnology in Medical Devices Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Nanotechnology in Medical Devices Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Nanotechnology in Medical Devices Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Nanotechnology in Medical Devices Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 3M
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Dentsply Sirona
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Thermo Fisher Scientific
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 PerkinElmer Inc
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 General Electric Company
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Ferro Corporation
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Eppendorf AG
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Merck KGaA
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 ZELLMECHANIK DRESDEN
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 TÜV Rheinland
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Medtronic
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Boston Scientific Corporation
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 BIOTRONIK
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 LivaNova PLC
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Demant A/S
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
18 Global Nanotechnology in Medical Devices Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • 3M
  • Dentsply Sirona
  • Thermo Fisher Scientific
  • PerkinElmer Inc
  • General Electric Company
  • Ferro Corporation
  • Eppendorf AG
  • Merck KGaA
  • ZELLMECHANIK DRESDEN
  • TÜV Rheinland
  • Medtronic
  • Boston Scientific Corporation
  • BIOTRONIK
  • LivaNova PLC
  • Demant A/S

Methodology

Loading
LOADING...

Table Information